GLPwatch
Trials (2081)
Page 10 of 35.
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
- GLP-1R Agonist Treatment for Opioid Use Disorder
- Impact of Bariatric Surgery and Liraglutide on Cognitive-Behavioral Markers of Long-Term Weight Loss in Obesity
- Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
- DIALYSIS-TIR Study
- A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.
- A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
- Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
- A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
- Research of Exenatide for Overweight/Obese PCOS Patients With IGR
- A Study of LY3537021 in Healthy Participants
- A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
- Rebalancing the Fat Content of the Heart and Muscles
- A Phase 3 Study of HS-20094 in Patients With T2DM
- Effect of Liraglutide on Vascular Inflammation in Type-2 Diabetes
- Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- The Semaglutide Study
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese
- A Study of LY3841136 in Overweight and Obese Participants
- Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.
- A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
- This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With Obesity
- The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
- Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
- 3mg Liraglutide for Overweight or Obesity
- A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
- A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector
- Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus
- A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants
- NC Works4Health: Reducing Chronic Disease Risks in Socioeconomically Disadvantaged, Unemployed Populations
- A Trial to Determine the Efficacy and Safety of Presendin in IIH
- A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
- Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
- A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
- Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)
- The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
- A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects
- A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)
- Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
- Emulation of the SOUL Diabetes Trial in Healthcare Claims
- Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
- The Medically Reproducing Bariatric Surgery (MRB) II Study
- Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
- A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
- A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
- Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)
- LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
- Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D
- Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
- Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)
- GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
- Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
- REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
- IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
- Pharmacogenomics of GLP1 Receptor Agonists
- Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
- Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
- Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function
- Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only